The story has been updated to include Ariosa Diagnostics test in California's program.

NEW YORK (GenomeWeb News) – Illumina, Natera, and Ariosa Diagnostics today separately announced that their non-invasive prenatal screening tests for detecting fetal aneuploidies will be offered to women in California through the state's prenatal screening program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.